Format

Send to

Choose Destination
Eur J Endocrinol. 2016 Oct;175(4):R147-56. doi: 10.1530/EJE-16-0178. Epub 2016 Apr 18.

MANAGEMENT OF ENDOCRINE DISEASE: Acromegaly and cancer: an old debate revisited.

Author information

1
Department of Internal MedicineEndocrine Division (SEMPR), Federal University of Paran√°, Curitiba, Brazil Boguszewskiclbogus@uol.com.br.
2
Consultant Endocrinologist/Honorary Senior LecturerDepartment of Endocrinology, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK.

Abstract

Based on experimental and animal models, epidemiological data from non-acromegaly populations, and longitudinal and cross-sectional cohorts of patients with acromegaly, a potential association between acromegaly and cancer has long been hypothesized, in particular colorectal cancer, and, to a lesser extent, breast, thyroid and prostate cancers. The exact mechanisms underlying this potential association have not been fully elucidated. Results from studies examining cancer incidence and mortality in acromegaly have been inconsistent, with some demonstrating increased risk, whereas others show no increase. This article reviews the existing data relating to cancer risk and mortality in acromegaly, exploring the limitations of study designs and the impact of changes in disease control and patient outcomes over time.

PMID:
27089890
DOI:
10.1530/EJE-16-0178
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Sheridan PubFactory
Loading ...
Support Center